Clinically Bharat

We Can Cover You

Healthcare

AI-powered device successfully treats blood clot in a 28-year-old, ET HealthWorld

Email :93

New Delhi: A 28-year-old man suffering from acute pulmonary thromboembolism (PE) due to a blood clot in his leg was successfully treated with a new AI-powered device, reported TOI.

Pulmonary thromboembolism, a form of pulmonary embolism (PE), occurs when a blood clot moves through the bloodstream and lodges in the lungs, potentially leading to irreversible harm. Doctors said that PE is among the most severe complications associated with blood clots. When a clot reaches the lungs, it can obstruct blood circulation and may result in significant damage or even death.

Dr VS Bedi, chairman of vascular surgery at Sir Gangaram Hospital, treated the patient using a device designed to remove blood clots with remarkable accuracy.

“The AI in the machine helps it target only the clots, avoiding sucking of normal blood and reducing the risks of severe blood loss causing hypotension and other complications associated with older methods,” he explained.

Conventional treatments for pulmonary embolism and deep vein thrombosis (DVT) have been associated with significant risks, often requiring procedures that carry dangers like bleeding and the need for repeated interventions.

The patient arrived at the hospital complaining of chest pain, breathing difficulty, and swelling in the left leg, which had persisted for three days. After seeking treatment at other hospitals without relief, the patient turned to Sir Gangaram Hospital.

Upon arrival, the patient was quickly taken for thrombosuction using the AI-powered device, which functions like a vacuum machine, sucking out all blood clots with minimal blood loss.

This approach eliminates the need for inferior vena cava (IVC) filter insertion and thrombolytic agent infusion, both of which can have dangerous side effects, such as internal bleeding in the brain, intestines, and other bleeding disorders.

  • Published On Sep 2, 2024 at 06:46 AM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post